About LenoMed
LenoMed is a company based in Shanghai (China) founded in 2014. LenoMed has raised $22.83 million across 3 funding rounds from investors including Eight Roads Ventures, Oriental Fortune Capital and Main Road Investment Fund Management. LenoMed operates in a competitive market with competitors including Tandem Diabetes, Kaleido, Modular Medical, Asante Solutions and Sooil Development, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.83 M (USD)
in 3 rounds
-
Latest Funding Round
$15.56 M (USD), Series C
May 12, 2021
-
Investors
Eight Roads Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of LenoMed
LenoMed has successfully raised a total of $22.83M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $15.56 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LenoMed
LenoMed has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures, Oriental Fortune Capital and Main Road Investment Fund Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by Oriental Fortune Capital.
|
Locked | Locked | Locked | |
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for LenoMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LenoMed
Investment portfolio details for LenoMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LenoMed
Detailed financials for LenoMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lenomed Comparisons
Peer comparison for LenoMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LenoMed
LenoMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tandem Diabetes, Kaleido, Modular Medical, Asante Solutions and Sooil Development, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of devices for continuous glucose monitoring and manual insulin delivery
|
|
| Locked | Locked | Locked |
Insulin pumps and monitoring software for diabetes are developed.
|
|
| Locked | Locked | Locked |
Insulin pumps are developed for continuous delivery to diabetic patients.
|
|
| Locked | Locked | Locked |
Insulin pump systems are developed and customized by Asante Solutions.
|
|
| Locked | Locked | Locked |
Develops insulin pumps and apps for diabetes care and blood sugar monitoring.
|
Detailed competitors of LenoMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lenomed
Complete news archive for LenoMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LenoMed
LenoMed was founded in 2014 and raised its 1st funding round 4 years after it was founded.
LenoMed is headquartered in Shanghai, China.
LenoMed is a funded company, having raised a total of $22.83M across 3 funding rounds to date.
Developer of closed-loop insulin delivery devices. It develops and manufactures insulin pumps, drug infusion pumps, and disposables. Its flagship product, the Innotech insulin pump is a closed-loop insulin delivery system which integrates CGM technology and insulin pump.
LenoMed's top competitors include Tandem Diabetes, Kaleido and Modular Medical.
LenoMed has 3 investors. Key investors include Eight Roads Ventures, Oriental Fortune Capital, and Main Road Investment Fund Management.